Real-time enrollment status for this generalised lipodystrophy clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 8:37 AM UTC
| NCT Number | NCT02325674 |
| Recruiting Status | Recruiting |
| Condition | Generalised Lipodystrophy |
| Phase | Clinical Trial |
| Target Enrollment | 100 participants |
| Active Locations | 16 sites in the US |
| Sponsor | Amryt Pharma |
| Last Updated on CT.gov | January 20, 2026 (Jan 20, 2026) |
As of July 13, 2026: Clinical trial NCT02325674 is currently recruiting participants. This clinical trial study for generalised lipodystrophy is actively seeking new participants at 16 locations across the United States. The study is sponsored by Amryt Pharma. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT02325674 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 16 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT02325674 was last updated Jan 20, 2026 (January 20, 2026). HelloStudys verifies this status automatically.